These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16196425)

  • 1. Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin.
    Santos RD; Chacra AP; Morikawa A; Vinagre CC; Maranhão RC
    Lipids; 2005 Jul; 40(7):737-43. PubMed ID: 16196425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.
    Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL
    Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated remnant-like particles in heterozygous familial hypercholesterolemia and response to statin therapy.
    de Sauvage Nolting PR; Twickler MB; Dallinga-Thie GM; Buirma RJ; Hutten BA; Kastelein JJ;
    Circulation; 2002 Aug; 106(7):788-92. PubMed ID: 12176948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia.
    Twickler TB; Dallinga-Thie GM; de Valk HW; Schreuder PC; Jansen H; Cabezas MC; Erkelens DW
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2422-7. PubMed ID: 11073847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation.
    Vuorio AF; Gylling H; Turtola H; Kontula K; Ketonen P; Miettinen TA
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):500-6. PubMed ID: 10669649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia.
    Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Nakamura H
    Atherosclerosis; 1995 Apr; 114(2):223-34. PubMed ID: 7605391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early statin therapy restores endothelial function in children with familial hypercholesterolemia.
    de Jongh S; Lilien MR; op't Roodt J; Stroes ES; Bakker HD; Kastelein JJ
    J Am Coll Cardiol; 2002 Dec; 40(12):2117-21. PubMed ID: 12505222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance.
    Yokoyama I; Yonekura K; Inoue Y; Ohtomo K; Nagai R
    J Nucl Cardiol; 2001; 8(4):445-51. PubMed ID: 11481566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
    Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
    Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
    Dane-Stewart CA; Watts GF; Mamo JC; Barrett PH; Martins IJ; Dimmitt SB; Redgrave TG
    Eur J Clin Invest; 2002 Jul; 32(7):493-9. PubMed ID: 12153549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia.
    Human JA; Ubbink JB; Jerling JJ; Delport R; Vermaak WJ; Vorster HH; Lagendijk J; Potgieter HC
    Clin Chim Acta; 1997 Jul; 263(1):67-77. PubMed ID: 9247729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil.
    Tilly-Kiesi M; Tikkanen MJ
    J Intern Med; 1991 May; 229(5):427-34. PubMed ID: 2040869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia.
    Vohl MC; Szots F; Lelièvre M; Lupien PJ; Bergeron J; Gagné C; Couture P
    Atherosclerosis; 2002 Feb; 160(2):361-8. PubMed ID: 11849659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of lovastatin and simvastatin on the diurnal periodicity of plasma mevalonate concentrations in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    Atherosclerosis; 2002 Nov; 165(1):137-44. PubMed ID: 12208479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.